ACIXF vs JNJ: Which Stock is Better?

Side-by-side comparison of Acarix AB (publ) and Johnson & Johnson in 2026

Comparison Updated:

ACIXF

Acarix AB (publ)

$0.03

JNJ

Johnson & Johnson

$218.21

Key Metrics Comparison

MetricACIXFJNJWinner
Market Cap$36.42M$525.73BJNJ
P/E RatioN/A21.10JNJ
EPS (TTM)$N/A$10.34JNJ
Revenue Growth1.4%0.1%ACIXF
Gross Margin86.2%68.4%ACIXF

Analyze ACIXF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACIXF or JNJ a better investment?

Comparing ACIXF and JNJ: Acarix AB (publ) has a market cap of $36.42M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACIXF and JNJ?

ACIXF (Acarix AB (publ)) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACIXF or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACIXF or JNJ?

ACIXF has higher revenue growth at 1.4% vs 0.1% for JNJ.

Which company is more profitable: ACIXF or JNJ?

Acarix AB (publ) (ACIXF) has higher gross margins at 86.2% compared to 68.4% for JNJ.

Which is the larger company: ACIXF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $36.42M for ACIXF.

Should I buy ACIXF or JNJ in 2026?

Both ACIXF and JNJ have investment merit. ACIXF trades at $0.03 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACIXF and JNJ stock?

Key differences: Market Cap ($36.42M vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (1.4% vs 0.1%), Gross Margin (86.2% vs 68.4%).

Popular Stock Comparisons